$12.69 +0.56 (4.617%) Lexicon Pharmaceuticals Inc - NASDAQ

Aug. 28, 2015 | 04:00 PM

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
12/12/2014Invus C.V.Senior Executive Officer150,000$0.880.50%
12/10/2014Invus C.V.Senior Executive Officer315,896$0.901.06%
2/28/2014SANDS ARTHUR TPresident & CEO-29,791$1.92-2.83%
2/28/2014Lapuerta PabloEVP, Clin Dev and CMO-11,992$1.92-30.93%
2/28/2014MAIN ALAN JEVP, Pharmaceutical Research-18,668$1.92-11.31%
2/28/2014Tessmer James FVP, Finance & Accounting-6,612$1.92-9.69%
2/28/2014ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer-18,186$1.92-6.13%
2/28/2014WADE JEFFREY LEVP, Corp Dev and CFO-16,297$1.92-9.81%
2/28/2013ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer-11,692$1.98-4.76%
2/28/2013WADE JEFFREY LEVP, Corp Dev and CFO-10,461$1.98-8.62%
2/28/2013Tessmer James FVP, Finance & Accounting-3,807$1.98-7.35%
2/28/2013SANDS ARTHUR TPresident & CEO-20,034$1.98-2.08%
2/28/2013Lapuerta PabloEVP, Clin Dev and CMO-4,725$1.98-36.35%
2/28/2013MAIN ALAN JEVP, Pharmaceutical Research-12,572$1.98-9.87%
1/31/2013WADE JEFFREY LEVP, Corp Dev and CFO-10,317$2.11-11.05%
1/31/2013SANDS ARTHUR TPresident & CEO-21,434$2.11-2.35%
1/31/2013ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer-13,499$2.11-6.23%
1/31/2013Tessmer James FVP, Finance & Accounting-4,310$2.11-10.29%
1/31/2013MAIN ALAN JEVP, Pharmaceutical Research-12,537$2.11-11.81%
10/23/2012Invus, CVSenior Executive Officer3,000,000$2.251.07%
10/23/2012Artal International S.C.A.Senior Executive Officer3,000,000$2.251.07%
2/28/2012Tessmer James FVP, Finance & Accounting-2,299$1.78-7.42%
2/28/2012MAIN ALAN JEVP, Pharmaceutical Research-5,907$1.78-9.20%
2/28/2012WADE JEFFREY LEVP, Corp Dev and CFO-4,959$1.78-7.43%
2/28/2012ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer-5,621$1.78-3.12%
2/28/2012SANDS ARTHUR TPresident & CEO-9,588$1.78-1.13%
12/22/2011Ulys, LLCSenior Executive Officer113,382,063$1.1382.77%
12/22/2011Ulys, LLCSenior Executive Officer1,622,184$1.1341.27%
12/22/2011MAIN ALAN JEVP, Pharmaceutical Research19,211$1.1342.72%
12/22/2011BARKER SAM LDirector34,000$1.1351.52%
12/22/2011SANDS ARTHUR TPresident & CEO25,000$1.133.18%
2/23/2011MAIN ALAN JEVP, Pharmaceutical Research-5,926$1.81-11.64%
2/23/2011Tessmer James FVP, Finance & Accounting-2,116$1.81-8.27%
2/23/2011SANDS ARTHUR TPresident & CEO-10,464$1.81-1.31%
2/23/2011WADE JEFFREY LEVP, Corp Dev and CFO-5,926$1.81-10.99%
2/23/2011ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer-7,881$1.81-4.73%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (LXRX), click here.
Trading Center

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!